Myelofibrosis


Related News

Ruxolitinib Reduces Spleen Size in Myelofibrosis

Mar 1, 2012

Two studies show benefits of Janus kinase inhibitor versus best available treatment or placebo


Baseline Factors May Predict Mortality Risk in Myelofibrosis

Jun 30, 2015

Researchers identify three risk factors indicating survival of a year or less, others await discovery


Exposure tied to B-cell acute lymphoid leukemia but not acute myeloid leukemia or T-cell ALL

Oct 8, 2010

Exposure tied to B-cell acute lymphoid leukemia but not acute myeloid leukemia or T-cell ALL